A serum described as improving texture may be advertised beside promises about wrinkles, firmness or a younger-looking face. Before treating those promises as one outcome, look at which assessment changed, when it changed and what the product was compared with.
Two serums, twenty participants
A May 2026 pilot randomized 20 women aged 50–65 to DRMTLGY Needle-less Growth Factor or SkinMedica TNS Advanced+ for 12 weeks. One used recombinant EGF; the comparator used human-derived conditioned media. Both groups used standardized cleanser and sunscreen. There was no vehicle-only group. [1]
Investigator texture and firmness ratings on a nonvalidated percentage-improvement scale favored the recombinant formulation at week eight, but the between-group differences were not significant at week twelve. Adapted wrinkle-scale ratings remained unchanged in both groups. Week-twelve imaging endpoints showed no significant between-group differences. [1]
The small, predominantly non-Hispanic White sample and short duration limit interpretation. Photograph-based social-perception ratings used an unvalidated instrument; they do not demonstrate improved employment or relationships. The study did not report a GLP-1 subgroup or measure restoration of lost facial volume. DRMTLGY funded the work; authors declared no conflicts. [1]
Ask which feature the offer addresses
Before shopping, describe the concern in ordinary words: roughness when washing, fine lines around the eyes, uneven color or a change in facial contour. These descriptions help you ask a more precise question than whether a serum “works.”
If a consultation concerns several features, ask the clinician to separate them in the proposed plan. Write down which product or procedure is intended for each concern, the expected scale of change, the review date and what would count as an inadequate response.
When someone cites a favorable study result, request the measurement and time point. A clinician's rating, an imaging output and a participant's satisfaction answer different questions. Keep those labels on any numbers you write down.
Also ask whether the evidence concerns the exact formulation being sold. The name of an ingredient category cannot supply the missing details of a different product's concentration, supporting ingredients or preparation.
Read the claim before reading the adjective
FDA explains that U.S. classification depends on intended use. Claims to treat disease or affect body structure or function can establish drug use; “cosmeceutical” is not a separate legal category. Cosmetics generally do not require premarket FDA approval, apart from certain color additives. [2]
If an advertisement says a product regenerates cells or restores tissue, ask the seller to explain the intended use and the evidence supporting that exact wording. Publication of a cosmetic trial does not itself establish FDA approval for the advertised claim.
Keep a copy of the offer and the product label. That lets you compare the claim with the full report instead of relying on a headline or a screenshot of a favorable chart. Ask whether the outcome was tested against another active product, a vehicle, or the participants' starting measurements.
Keep the everyday routine manageable
The American Academy of Dermatology recommends starting with sunscreen and moisturizer, then choosing a product for one remaining concern. It advises broad-spectrum, water-resistant sunscreen with SPF 30 or higher and reapplication every two hours outdoors. Adding several anti-aging products close together can irritate skin. [3]
Bring a list of what you already use, including prescription creams, cleansers, sunscreen and occasional peels. Include the order and frequency of use. If something stings or causes visible irritation, describe that experience before agreeing to another addition.
Ask which existing steps should stay, which require review and how the proposed product would fit. Get instructions from the clinician managing any prescription skin treatment before changing that treatment to match a cosmetic trial.
Set a spending limit before buying a package. Ask about the bottle size, anticipated replacement schedule, cancellation terms and whether follow-up is included. Those details belong beside the evidence when deciding whether an optional purchase fits your priorities.
Bring the concern to the appropriate appointment
For a change noticed during GLP-1 treatment, tell the treating clinician when it appeared and what else changed around that time. Bring the medicine list and the cosmetic product list. Ask who should assess the skin concern and which treatment questions belong with your prescriber.
You can say: “I am considering this serum for this specific feature. Which evidence applies to me, what would we assess at follow-up, and what remains uncertain?” Keep a brief record of the answer rather than trying to reproduce every assessment used in a research clinic.
Printed book
How to Keep Your Face on GLP-1
$12.95 + free shipping
Order Now30 day money back guarantee
This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.
Read next
Skin careAcne Scars During GLP-1: Identify the Mark Before Treatment→Skin & researchAdapalene for Photoaging: Check the 0.3% Trial and the Acne Label→Sources
- Abud and colleagues: Two growth-factor serums, pilot comparisonJournal of Cosmetic Dermatology; May 18, 2026; full report via PMC↩ Back to text
- Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration; checked October 30, 2026↩ Back to text
- How to select anti-aging skin care productsAmerican Academy of Dermatology; checked October 30, 2026↩ Back to text

